BlueRock Therapeutics
Toronto
About BlueRock Therapeutics
BlueRock Therapeutics is a biotech company that plans to develop induced pluripotent stem cell (iPSC) therapies to cure a range of diseases using an industry-leading platform. One of the initial programs is to regenerate heart muscle in patients who have had a heart attack (myocard infarction, MI) or are suffering from chronic heart failure, leading causes of morbidity and mortality worldwid.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 251 – 500
- Estimated revenue: $10K – $50K
- Total funding: $225.0M
- Funding stage: M&A
- Last round: Series A (Dec 2016)
- Website: bluerocktx.com
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/bluerock-therapeutics-26765 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.